Editorial
Corrigendum
Advice has changed for hormone therapy in the WHI era
Endogenous anti-oxidants in pregnancy and preeclampsia
Hormone therapy in the WHI era
Antenatal screening for Down syndrome in New Zealand
Maternal serum activin A and the prediction of intrauterine growth restriction
Subcutaneous sterile water injection for labour pain
A medical management of interstitial ectopic pregnancy
Guidelines following hydatidiform mole
Persistent trophoblast disease following partial molar pregnancy
Vacuum-assisted delivery
Postmenopausal hormone therapy
Effect of inhaled glucocorticoid treatment on placental 11β-hydroxysteroid dehydrogenase type 2 activity and neonatal birthweight in pregnancies complicated by asthma
No more surrogate end-points in randomised trials
Activin A, hypoxia and the prediction of obstetric outcomes
Activin-A secretion is increased in the eutopic endometrium from women with essndometriosis
Molecular profiling of human endometrium during the menstrual cycle
A possible role for progesterone metabolites in human parturition
Do women with polycystic ovary syndrome really have predisposition to atherosclerosis?
Successful pregnancy in a woman with glycogen storage disease type III
Re
Re
Re
Re
Re
Re
Re
Re
Editor's comment
Re
Re
Re
Re